Range
25.71 - 27.63
Vol / Avg.
23.8K/-
Div / Yield
-
52 Wk
- - -
Mkt Cap
713M
Payout Ratio
-
Open
26.74
P/E
-
EPS
-0.33
Shares
25.9M
Outstanding
25.9M
Total Float
21.2M
Sector: Health Care.Industry: Biotechnology
Immuneering Corpbiopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies.

Earnings

see more
Q3 2021Est.ActualSurprise
EPS
(EXPECTED)2021-12-09
REV
Q2 2021Est.ActualSurprise
EPS-1.480-1.610 -0.1300
REV330.000K660.040K330.040K

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Related Companies

TickerCompanyChg %Mkt Cap
IMRXImmuneering2.96%713M

Immuneering Questions & Anwsers

Q

How do I buy Immuneering (IMRX) stock?

A

You can purchase shares of Immuneering (NASDAQ: IMRX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Immuneering's (IMRX) competitors?

Q

What is the target price for Immuneering (IMRX) stock?

A

The latest price target for Immuneering (NASDAQ: IMRX) was reported by Cowen & Co. on August 24, 2021. The analyst firm set a price target for 0.00 expecting IMRX to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Immuneering (IMRX)?

A

The stock price for Immuneering (NASDAQ: IMRX) is $27.49 last updated Fri Sep 24 2021 20:00:02 GMT+0000 (Coordinated Universal Time).

Q

Does Immuneering (IMRX) pay a dividend?

A

There are no upcoming dividends for Immuneering.

Q

When is Immuneering (NASDAQ:IMRX) reporting earnings?

A
Immuneering’s Q3 earnings are confirmed for after-market on December 9, 2021.
Q

Is Immuneering (IMRX) going to split?

A

There is no upcoming split for Immuneering.

Q

What sector and industry does Immuneering (IMRX) operate in?

A

Immuneering is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.